Big Healthcare Companies with a Heavy Debt Load to Watch

The Cheat Sheet

Wall St. Watchdog reveals information about heavily indebted large cap companies in the Healthcare sector:

  • Pfizer Inc. ( NYSE:PFE): This company holds $28,609,000,000 in debt on its balance sheet, against $60,468,000,000 in assets, for a debt-to-assets ratio of 0.47. The stock recently traded at$16.66 and its market capitalization is $131,632,800,000. About the company: Pfizer, Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals.  The Company’s products include prescription pharmaceuticals, non-prescription medications, and animal health products such as anti-infective medicines and vaccines.
  • Novartis AG (ADR) : This company holds $24,658,000,000 in debt on its balance sheet, against $26,685,000,000 in assets, for a debt-to-assets ratio of 0.92. The stock recently traded at$54.34 and its market capitalization is $149,790,500,000. About the company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.
  • Johnson + Johnson : This company holds $23,072,000,000 in debt on its balance sheet, against $47,307,000,000 in assets, for a debt-to-assets ratio of 0.49. The stock recently traded at$61.12 and its market capitalization is $167,538,700,000. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • GlaxoSmithKline plc (ADR) : This company holds $20,962,496,190 in debt on its balance sheet, against $26,274,384,502 in assets, for a debt-to-assets ratio of 0.80. The stock recently traded at$39.61 and its market capitalization is $102,960,026,880. About the company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders.
  • McKesson Corporation : This company holds $18,726,000,000 in debt on its balance sheet, against $22,357,000,000 in assets, for a debt-to-assets ratio of 0.84. The stock recently traded at$70.91 and its market capitalization is $17,465,440,000. About the company: McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.
  • Abbott Laboratories : This company holds $17,262,430,000 in debt on its balance sheet, against $22,317,530,000 in assets, for a debt-to-assets ratio of 0.77. The stock recently traded at$48.06 and its market capitalization is $74,809,070,000. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • AstraZeneca plc (ADR) : This company holds $16,787,000,000 in debt on its balance sheet, against $25,131,000,000 in assets, for a debt-to-assets ratio of 0.67. The stock recently traded at$41.55 and its market capitalization is $57,840,620,000. About the company: AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.
  • Sanofi SA (ADR) : This company holds $16,689,663,163 in debt on its balance sheet, against $38,433,487,055 in assets, for a debt-to-assets ratio of 0.43. The stock recently traded at$33.07 and its market capitalization is $92,116,764,125. About the company: Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
  • Merck + Co., Inc. : This company holds $15,641,000,000 in debt on its balance sheet, against $29,064,000,000 in assets, for a debt-to-assets ratio of 0.54. The stock recently traded at$29.94 and its market capitalization is $92,412,350,000. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Cardinal Health, Inc. : This company holds $13,369,500,000 in debt on its balance sheet, against $16,315,900,000 in assets, for a debt-to-assets ratio of 0.82. The stock recently traded at $37.99 and its market capitalization is $13,318,780,000. About the company: Cardinal Health, Inc. provides complementary products and services to healthcare providers and manufacturers. The Company’s services include pharmaceutical distribution, health-care product manufacturing, distribution and consulting services, drug delivery systems development, pharmaceutical packaging, automated dispensing systems manufacturing, and retail pharmacy franchising.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

Rates

View Comments (0)